GlassScriptPhysician profile
Elisabeth Harmeyer
NPI 1750036117
$9,344.13
in general payments reported to CMS, 2019-2025
40 companies · $3,415 in 2025
The $3,415 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $675 · 2023: $2,217 · 2024: $3,036 · 2025: $3,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,668.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,511.23 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $1,197.83 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $794.85 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $762.33 | 2022-2025 | |
| Axsome Therapeutics, INC. | $581.76 | 2024-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $559.37 | 2022-2025 | Camzyos, Eliquis |
| Phathom Pharmaceuticals, INC. | $474.66 | 2024-2025 | Voquezna |
| Astellas Pharma US INC | $394.22 | 2022-2025 | Veozah, Myrbetriq |
| Dexcom, INC. | $380.22 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Pfizer INC. | $349.85 | 2023-2025 | |
| Aimmune Therapeutics, INC. | $323.72 | 2024-2025 | Zenpep |
| Bayer Healthcare Pharmaceuticals INC. | $274.62 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $261.17 | 2023-2024 | Euflexxa |
| Exact Sciences Corporation | $161.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Recor Medical INC | $138.40 | 2024 | Paradise Renal Denervation System |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisabeth Harmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.